Dsm-firmenich to Build Centralized Financing Structure Under Cross Guarantee Deal

Published on 2024-05-31 at 04:34 - Modified on 2024-05-31 at 04:35

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about DSM-Firmenich

Sensient Technologies Corporation : Taste and color	07-17
AlphaValue/Baader Europe Upgrades DSM-Firmenich to Buy, Lifts PT	07-15	MT
DSM-Firmenich Expected to Receive Three Final Bids for Animal Feed Unit	07-07	MT
DSM-Firmenich Expected to Receive Three Final Bids for Animal Feed Unit	07-07	MT
DSM-Firmenich Expected to Receive Three Final Bids for Animal Feed Unit	07-07	MT
Dsm-firmenich's animal feed unit sale attracts three final bidders, Dutch paper reports	07-07	RE
DSM-Firmenich to Redeem EUR750 Million Loan Notes in August	07-01	MT
DSM-Firmenich Doubles Share Repurchase Program to EUR1 Billion	06-27	MT
Swiss stocks - Factors to watch on June 16	06-16	RE
Honeywell & DSM-Firmenich Settle Disputes Related To Honeywell Spectra MG BIO Blue Fiber	06-13	RE
Novonesis Closes Purchase of DSM-Firmenich's Stake in Feed Enzymes Alliance	06-02	MT
Dsm-firmenich Completes EUR 1.5 Bln Sale Of Stake In Feed Enzymes Alliance To Novonesis	06-02	RE
Novonesis A/S (CPSE:NSIS B) completed the acquisition of remaining 50% stake in Feed Enzymes Alliance from DSM-Firmenich AG.	06-01	CI
ABB Lands Automation, Electrical Systems Order from DSM-Firmenich	05-22	MT
Dsm-Firmenich Opens Its Princeton Baking Innovation Center in New Jersey	05-20	CI
DSM-FIRMENICH : Temporary vitamin effect lasts longer	05-02
The stock market has just gained 15% but remains in the fog	04-30
Chemicals maker dsm-firmenich well-placed to mitigate tariff impact	04-30	RE
Chemicals maker dsm-firmenich well-placed to mitigate tariff impact	04-30	RE
DSM-Firmenich AG, Q1 2025 Sales/ Trading Statement Call, Apr 30, 2025	04-30
DSM-Firmenich reports Q1 results slightly below market expectations	04-30	RE
DSM-Firmenich Q1 Sales Rise	04-30	MT
Dsm-firmenich Q1 Sales EUR 3.274 Bln	04-30	RE
DSM-Firmenich Q1 Adj. EBITDA Margin Up At 19.9%	04-30	RE
DSM-Firmenich Appoints New Chief Legal, Risk and Compliance Officer	04-08	MT